We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
-4.03%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$29.4B
AUM Growth
-$873M
Cap. Flow
+$534M
Cap. Flow %
1.81%
Top 10 Hldgs %
8.87%
Holding
3,036
New
582
Increased
766
Reduced
960
Closed
600

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$244M
2
ENPH icon
Enphase Energy
ENPH
+$229M
3
GSK icon
GSK
GSK
+$223M
4
ACN icon
Accenture
ACN
+$209M
5
C icon
Citigroup
C
+$209M

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Healthcare 13.67%
3 Financials 9.64%
4 Industrials 8.71%
5 Consumer Discretionary 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LZ icon
2226
LegalZoom.com
LZ
$988M
$89K ﹤0.01%
10,400
-40,691
-80% -$421K
SYBX
2227
DELISTED
Synlogic
SYBX
$89K ﹤0.01%
6,267
-220
-3% -$3.37K
DMRA
2228
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.84B
$88K ﹤0.01%
1,862
-670
-26% -$34K
HCWB icon
2229
HCW Biologics
HCWB
$5.45M
$87K ﹤0.01%
159
-6
-4% -$3.44K
HMY icon
2230
Harmony Gold Mining
HMY
$12.3B
$87K ﹤0.01%
+35,653
New +$103K
MPU icon
2231
Mega Matrix
MPU
$13.7M
$87K ﹤0.01%
51,529
-78,032
-60% -$97.9K
STTK icon
2232
Shattuck Labs
STTK
$694M
$84K ﹤0.01%
31,103
-17,055
-35% -$64K
TSHA icon
2233
Taysha Gene Therapies
TSHA
$1.89B
$84K ﹤0.01%
43,378
-24,266
-36% -$88.1K
AATC
2234
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
$83K ﹤0.01%
18,212
-2,771
-13% -$14K
ELDN icon
2235
Eledon Pharmaceuticals
ELDN
$285M
$82K ﹤0.01%
29,737
-1,400
-4% -$4.46K
NVVE
2236
DELISTED
Nuvve Holding Corp
NVVE
0
LOTZ
2237
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$82K ﹤0.01%
273,853
-189,738
-41% -$82.9K
DSX icon
2238
Diana Shipping
DSX
$301M
$81K ﹤0.01%
+27,992
New +$111K
LIDR icon
2239
AEye
LIDR
$61.1M
$81K ﹤0.01%
+2,446
New +$136K
MACK
2240
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$81K ﹤0.01%
21,519
-3,400
-14% -$15.7K
PLM
2241
DELISTED
PolyMet Mining Corp.
PLM
$81K ﹤0.01%
28,137
-29,354
-51% -$87.6K
TDUP icon
2242
ThredUp
TDUP
$422M
$79K ﹤0.01%
43,143
-264,898
-86% -$664K
XXII
2243
22nd Century Group
XXII
$1.48M
0
RCEL icon
2244
Avita Medical
RCEL
$240M
$78K ﹤0.01%
14,860
-43,250
-74% -$267K
CUE icon
2245
Cue Biopharma
CUE
$114M
$76K ﹤0.01%
1,137
-3,225
-74% -$277K
UP icon
2246
Wheels Up
UP
$198M
$76K ﹤0.01%
330
-305
-48% -$122K
SEEL
2247
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$76K ﹤0.01%
19
-109
-85% -$429K
VINC
2248
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$75K ﹤0.01%
2,734
-270
-9% -$7.77K
HYZN
2249
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$75K ﹤0.01%
+880
New +$116K
PYXS icon
2250
Pyxis Oncology
PYXS
$236M
$74K ﹤0.01%
37,677
-4,619
-11% -$12.1K

Similar funds

Two Sigma Investments's Q3 2022 Portfolio in Review

As of Q3 2022, Two Sigma Investments held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.

Two Sigma Investments's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Two Sigma Investments's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
  • Two Sigma Investments added most to GSK in Q3 2022, an estimated $223M increase.
  • Two Sigma Investments's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
  • Two Sigma Investments fully exited Bank of America in Q3 2022, selling an estimated $225M.
  • Two Sigma Investments's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
  • Two Sigma Investments opened 582 new positions and closed 600 in Q3 2022.
  • Two Sigma Investments's portfolio value fell 2.9% quarter-over-quarter to $29.4B.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.